NCT00241631View on ClinicalTrials.gov

Enhancement of in-Vitro GC Function in Patients With COPD

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
COPD
Interventions
DRUG

Fluticasone Propionate

500 u

DRUG

placebo

DRUG

Theophylline

Theophylline placebo capcule

Trial Locations (1)

SL4 3DP

Windsor chest clinic KEVII Hospital, Windsor

Sponsors
All Listed Sponsors
collaborator

Mitsubishi Tanabe Pharma Corporation

INDUSTRY

collaborator

Medical Research Council

OTHER_GOV

lead

Imperial College London

OTHER